Search

everythinglearnresearchcommunity

for

Search:↓

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Quercetin effectively treated and prevented hair loss in mice.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Using old drugs for new uses can help treat rare immune deficiencies.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

ADM scaffolds help skin heal by promoting a healing-type immune response.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Cyclosporine A helps hair grow by blocking a process that would otherwise cause hair cells to die.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Mouse models help understand alopecia areata and find treatments.

Low-level Laser Therapy may help reduce inflammation, pain, and aid healing, but more research is needed to confirm its effectiveness and establish standard treatment guidelines.